Analysis of the Gene That Encodes the Complement Regulatory Protein, Membrane Inhibitor of Reactive Lysis (CD59): Identification of an Alternatively Spliced Exon and Characterization of the Transcriptional Regulatory Regions of the Promoter

Journal of Immunology

Volumn 157, Issue 4, 1996, Pages 1659-1668

  Holguin, Mark H ^a   Martin, Carol B ^b   Eggett, Therese ^b   Parker, Charles J ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; COMPLEMENTARY DNA; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR ANTIGEN;

ARTICLE; CELL CULTURE; EXON; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MONONUCLEAR CELL; MYELOID LEUKEMIA; NEOPLASM; PATHOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; RNA SPLICING;

ANTIGENS, CD59; ANTIGENS, NEOPLASM; DNA, COMPLEMENTARY; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES; HUMANS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LEUKOCYTES, MONONUCLEAR; NEOPLASMS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RNA SPLICING; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030586623     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Holguin, M. H., L. R. Fredrick, N. J. Bernshaw, and C. J. Parker. 1989. Isolation and characterization of a protein from normal erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J. Clin. Invest. 84:7.
2. Davies, A., D. L. Simmons, G. Hale, R. A. Harrison, H. Tighe, P. J. Lachmann, and H. Waldmann. 1989. CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 170:637.
3. Sugita, Y., Y. Nakano, and M. Tomita. 1988. Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels. J. Biochem. 104:633.
4. Nose, M., M. Katoh, N. Okada, M. Kyogoku, and H. Okada. 1990. Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Immunology 70:145.
5. Okada, N., R. Harada, T. Fujita, and H. Okada. 1989. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int. Immunol. 1:205.
6. Harada, R., N. Okada, T. Fujita, and H. Okada. 1990. Purification of 1F5 antigen which prevents complement attack on homologous cells. J. Immunol. 144:1823.
7. Meri, S., B. P. Morgan, A. Davies, R. H. Daniels, M. G. Olavesen, H. Waldmann, and P. J. Lachmann. 1990. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 72:1.
8. Rollins, S. A., and P. J. Sims. 1990. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J. Immunol. 144:3478.
9. Nicholson-Weller, A., J. P. March, S. I. Rosenfeld, and K. F. Austen. 1983. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein decay accelerating factor. Proc. Natl. Acad. Sci. USA 80:5066.
10. Takeda, J., T. Miyata, K. Kawagoe, Y. Iida, Y. Endo, T. Fujita, M. Takahashi, T. Kitani, and T. Kinoshita. 1993. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703.
11. Rosse, W. F., and C. J. Parker. 1985. Paroxysmal nocturnal hemoglobinuria: an acquired membrane disorder. Clin. Haematol. 14:105.
12. Holguin, M. H., L. A. Wilcox, N. J. Bernshaw, W. F. Rosse, and C. J. Parker. 1989. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria. J. Clin. Invest. 84:1387.
13. Yamashina, M., E. Ueda, T. Kinoshita, T. Takami, A. Ojima, H. Ono, H. Tanaka, N. Kondo, T. Orii, N. Okada, H. Okada, K. Inoue, and T. Kitani. 1990. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 323:1184.
14. Motoyama, N., N. Okada, M. Yamashina, and H. Okada. 1992. Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene. Eur. J. Immunol. 22:2669.
15. Matsuo, S., H. Nishikage, F. Yoshida, A. Nomura, A. J. Piddlesden, and B. P. Morgan. 1994. Role of CD59 in experimental glomerulonephritis in rats. Kidney Int. 46:191.
16. Piddlesden, S. I., and B. P. Morgan. 1993. Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis. J. Neuroimmunol. 48:169.
17. Rooney, I. A., and B. P. Morgan. 1990. Protection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteins. Immunology 71:308.
18. Rooney, I. A., A. Davies, D. Griffiths, J. D. Williams, M. Davies, S. Meri, P. J. Lachmann, and B. P. Morgan. 1991. The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells. Clin. Exp. Immunol. 83:251.
19. Fodor, W. L., B. L. Williams, L. A. Malis, J. A. Madri, S. A. Rollins, J. W. Knight, W. Velander, and S. P. Squinto. 1994. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc. Natl. Acad. Sci. USA 91:11153.
20. McCurry, K. R., D. L. Kooyman, C. G. Alvarado, A. H. Cotterell, M. J. Martin, J. S. Logan, and J. L. Platt. 1995. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat. Med. 1:423.
21. Philbrick, W. M., R. G. E. Palfree, S. E. Maher, M. M. Bridgett, S. Sirlin, and A. L. M. Bothwell. 1990. The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility. Eur. J. Immunol. 20:87.
22. Holguin, M. H., C. B. Martin, J. H. Weis, and C. J. Parker. 1993. Enhanced expression of the complement regulatory protein, membrane inhibitor of reactive lysis (CD59), is regulated at the level of transcription. Blood 82:968.
23. Sawada, R., K. Ohashi, M. Okano, M. Hattori, N. Minato, and M. Naruto. 1989. Complementary DNA sequence and deduced peptide sequence for CD59/ MEM-43 antigen, the human homologue of murine lymphocyte antigen Ly-6C. Nucleic Acids Res. 17:6728.
24. Petranka, J. G., D. E. Fleenor, K. Sykes, R. E. Kaufman, and W. F. Rosse. 1992. Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein. Proc. Natl. Acad. Sci. USA 89:7876. Erratum: Proc. Natl. Acad. Sci. USA 1993 90:5878.
25. Tone, M., L. A. Walsh, and H. Waldmann. 1992. Gene structure of human CD59 and demonstration that discrete mRNAs are generated by alternative polyadenylation. J. Mol. Biol. 227:971.
26. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. Suppl. 21:77.
27. Thomas, P. S. 1980. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 77:5201.
28. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463.
29. Graves, B. J., S. P. Eisenberg, D. M. Coen, and S. L. McKnight. 1985. Alternate utilization of two regulatory domains within the Moloney murine sarcoma virus long terminal repeat. Mol. Cell. Biol. 5:1959.
30. Chirgwin, J. M., A. E. Przbyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.
31. Wittwer, W. T., G. C. Fillmore, and D. J. Garling. 1990. Minimizing the time required for DNA amplification by efficient heat transfer to small samples. Anal. Biochem. 186:328.
32. Okada, H., Y. Nagami, K. Takahashi, N. Okada, T. Hideshima, H. Takizawa, and J. Kondo. 1989. 20 kDa homologous restriction factor of complement resembles T cell activating protein. Biochem. Biophys. Res. Commun. 162:1553.
33. Sugita, Y., T. Tobe, E. Oda, M. Tomita, K. Yasukawa, N. Yamaji, T. Takemoto, K. Furuichi, M. Takayama, and S. Yano. 1989. Molecular cloning and characterization of MACIF, an inhibitor of membrane channel formation of complement. J. Biochem. 106:555.
34. Melton, D. W., D. S. Konecki, J. Brennand, and C. T. Caskey. 1984. Structure, expression, and mutation of the hypoxanthine phosphoribosyltransferase gene. Proc. Natl. Acad. Sci. USA 81:2147.
35. Reynolds, G. A., S. K. Basu, T. F. Osborne, D. J. Chin, G. Gil, M. S. Brown, J. L. Goldstein, and K. L. Luskey. 1984. HMG CoA reductase: a negatively regulated gene with unusual promoter and 5′ untranslated regions. Cell 30:275.
36. Ishii, S., Y-H. Xu, R. H. Stratum, B. A. Roe, G. T. Merlino, and I. Pastan. 1985. Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. USA 82:4920.
37. Thomas, D. J., and D. M. Lublin. 1993. Identification of 5′-flanking regions affecting expression of the human decay accelerating factor gene and their role in tissue-specific expression. J. Immunol. 150:151.
38. Dynan, W. S., and R. Tjian. 1983. The promoter-specific transcription factor SP1 binds to upstream sequences in the SV40 early promoter. Cell 35:79.
39. Briggs, M. R., J. T. Kadonaga, S. B. Bell, and R. Tjian. 1986. Purification and biochemical characterization of the promoter-specific transcription factor, SP1. Science 234:47.
40. Gidoni, D., J. T. Kadonaga, H. Barrera-Saldana, K. Takahashi, P. Chambon, and R. Tjian. 1985. Bidirectional SV40 transcription mediated by tandem Sp1 binding interactions. Science 230:511.
41. Kadonaga, J. T., A. J. Courey, J. Ladika, and R. Tjian. 1988. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science 242:1566.
42. Pugh, B. F., and R. Tjian. 1990. Mechanism of transcriptional activation by SP1: evidence for coactivators. Cell 61:1187.
43. Frohman, M. A., M. K. Dush, and G. R. Martin. 1988. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 85:8998.
44. Marchbank, K. J., B. P. Morgan, and C. W. Van den Berg. 1995. Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack. Immunology 85:146.
45. Kadonaga, J. T., K. R. Carner, F. R. Masiarz, and R. Tjian. 1987. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51:1079.
46. Li, R., J. D. Knight, S. P. Jackson, R. Tjian, and R. R. Botchan. 1991. Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell 65:493.
47. Seto, E., B. Lewis, and T. Shenk. 1993. Interaction between transcription factors SP1 and YY1. Nature 365:462.